ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,928Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 1844

$618K Total Retail Price of All Prescriptions

Rank: 219 out of 1844

413 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 10,999 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 838 722 1 1
HYDROCODONE-ACETAMINOPHEN 640 505 S3 2 2
ATENOLOL 483 422 3 17
FUROSEMIDE 384 342 4 7
OMEPRAZOLE 357 273 5 5
PRAVASTATIN SODIUM 333 287 6 10
SIMVASTATIN 271 215 7 3
WARFARIN SODIUM 259 250 8 13
TRIAMTERENE-HCTZ 230 212 9 48
METFORMIN HCL 229 167 10 8
AMLODIPINE BESYLATE 213 202 11 6
SPIRONOLACTONE 178 154 12 60
PREDNISONE 160 126 13 40
GLIPIZIDE ER 143 110 14 79
MELOXICAM 142 110 15 28
ZOLPIDEM TARTRATE 140 111 16 23
FLUOXETINE HCL 137 116 17 41
GABAPENTIN 134 114 18 15
CITALOPRAM HBR 130 103 19 19
POTASSIUM CHLORIDE 130 110 19 16
LOSARTAN-HYDROCHLOROTHIAZIDE 129 112 21 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 98 22 20
ATORVASTATIN CALCIUM 122 111 23 12
SYNTHROID 120 120 24 55
LISINOPRIL 119 104 25 4
DOXYCYCLINE HYCLATE 118 96 26 90
HYDROCHLOROTHIAZIDE 118 102 26 9
LOSARTAN POTASSIUM 116 101 28 24
LOVASTATIN 96 79 29 44
TRAZODONE HCL 95 81 30 43
SERTRALINE HCL 94 82 31 21
CLOTRIMAZOLE-BETAMETHASONE 91 70 32 202
NYSTATIN 91 70 32 85
CLONAZEPAM 86 36 34 297
MIRTAZAPINE 85 79 35 49
ESTRADIOL 84 27 R 36 181
CIPROFLOXACIN HCL 84 58 36 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 58 38 73
DICYCLOMINE HCL 77 63 38 197
FLUCONAZOLE 74 42 40 187
TAMSULOSIN HCL 72 72 41 27
OXYCODONE HCL-ACETAMINOPHEN 72 24 S2 41 83
NIFEDIPINE ER 70 58 43 154
JANUVIA 70 56 43 77
ALLOPURINOL 70 70 43 29
CYMBALTA 69 41 46 36
PROMETHAZINE HCL 69 36 R 46 88
CLINDAMYCIN HCL 68 48 48 325
KLOR-CON 10 68 59 48 123
BUPROPION HCL SR 67 46 50 196
RANITIDINE HCL 65 38 51 38
SULINDAC 64 58 52 271
CRESTOR 62 34 53 30
DOXAZOSIN MESYLATE 59 50 54 110
TRAMADOL HCL 59 44 54 18
OXYBUTYNIN CHLORIDE 56 44 56 103
DILTIAZEM 24HR ER 55 31 57 146
METOPROLOL SUCCINATE 55 53 57 14
PANTOPRAZOLE SODIUM 55 49 57 32
PROPYLTHIOURACIL 54 45 60 434
JANTOVEN 52 52 61 199
CEFDINIR 52 47 61 169
GLIPIZIDE 51 43 63 70
SPIRONOLACTONE-HCTZ 50 44 64 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.